
    
      OBJECTIVES:

        -  To identify new genetic abnormalities associated with acute myeloid leukemia (AML) in
           patients with Down syndrome through whole-genome sequencing.

      OUTLINE: This is a multicenter study.

      Extracted DNA and RNA from cryopreserved specimens are analyzed for genomic sequencing, gene
      mutation, and microarray analysis.
    
  